Tissue injury leads to activation of resident stromal, parenchymal and immune cells to initiate reparative processes that, if unresolved, can lead to fibrosis and organ damage. The directionality of effect between fibrosis and inflammation in the lung has been a point of debate for many years. Here, we tested the hypothesis that Interleukin 11 (IL11) signaling in fibroblasts is of primary importance for pulmonary fibrosis and that this event is upstream of lung inflammation. We generated mice with loxP-flanked Il11ra1 alleles and crossed them to a Col1a2-CreERT strain to enable Il11ra1 deletion in adult fibroblasts (Il11ra1-CKO mice). Lung fibroblasts from Il11ra1-CKO mice were selectively deleted for Il11ra1 and refractory to TGFβ1 stimulation. In the mouse model of bleomycin-induced lung fibrosis, Il11ra1-CKO mice had markedly reduced pulmonary fibrosis and lesser lung damage, which was accompanied by diminished ERK activation in the stromal compartment. Bleomycin lung injury in Il11ra1-CKO mice was also associated with diminished STAT3 activation in inflammatory cells, fewer pulmonary immune cell infiltrates and almost complete inhibition of NF-kB activation. These data reveal an essential role for IL11 signaling in fibroblasts for lung fibrosis and show that inflammation in the lung can be secondary to stromal activation.
INTRODUCTION
Fibrosis is a final common pathology underlying many chronic diseases and a major cause of morbidity and mortality (1) . The main effector cells in fibrotic diseases are tissue-resident fibroblasts that are activated by local signals in injured tissues to become myofibroblasts. Myofibroblasts secrete large amounts of collagen, are pro-inflammatory and invade and disrupt tissue architecture, causing organ dysfunction (2, 3) . There remains an unresolved issue as to the timing and directionality between tissue fibrogenesis and inflammation, notably in the lung and specifically in idiopathic pulmonary fibrosis (IPF).
Over decades, opinion has swung from the view that IPF is an inflammation-first-driven condition to a disease better characterized by prolonged epithelial injury, aberrant wound healing and, perhaps, a secondary wave of inflammation (4) . In recent years, a primary immune role for Th2 polarized T cells and the Th2 cytokine IL13 gained favor in IPF fibrogenesis but targeting IL13 in clinical trials was ineffective (5) . It remains to be resolved as to what are the key sentinel cells in the lung, immune and/or stromal, and how fibrosis and inflammation arise temporally: in series, in parallel or independently (6, 7) . IL11 is a member of the IL6 family of cytokines that share the use of the GP130 receptor as part of their multimeric receptor-ligand complexes for signal transduction. IL11 is secreted when tissue-resident fibroblasts are activated by profibrotic stimuli and binds IL11RA, which is highly expressed on stromal cells (e.g. fibroblasts and smooth muscle cells) (2) . In recent studies, we documented an important role for IL11 in heart, kidney, lung and liver fibrosis (2, 3, 8) where it drives fibroblasts or hepatic stellate cells to become disease-causing myofibroblasts.
In mice, fibroblast-specific transgenic expression or systemic administration of IL11 induces fibroblast-to-myofibroblast transformation, causing widespread organ fibrosis, whereas mice with germline, global Il11ra1 deletion are protected from fibrosis (2, 3, 8) . Furthermore, inhibition of IL11 signaling using neutralizing antibodies prevents and reverses established fibrosis and inflammation in a mouse model of lung injury and in diet-induced non-alcoholic steatohepatitis (3, 8) . Whilst these studies robustly annotate IL11 as a profibrotic factor that appears also important for inflammation, they do not address the directionality of these effects. We set out to dissect the fibroblast-specific effects of IL11 signaling to examine the relationship between fibroblast activation and inflammation in the lung.
Here we report the generation of a new Il11ra1-floxed mouse that we crossed to a Col1a2-CreERT strain to enable Il11ra1 deletion in a temporal and conditional manner, specifically in adult fibroblasts. We subjected these mice to bleomycin (BLM) lung injury to explored the hypothesis that fibroblast-specific IL11 signaling is of primary importance for lung fibrosis and that IL11-mediated myofibroblast activation is required for and precedes lung inflammation.
COMBINED RESULTS AND DISCUSSION
In our previous studies, we used the global l11ra1 knockout mice to examine the role of IL11 signaling in various models of fibrotic disease. To further understand the cell-autonomous effects of IL11 signaling in fibrogenesis, we generated a Il11ra1-floxed mouse whereby Il11ra1 could be conditionally deleted in a cell type-specific and temporal manner. Using CRISPR/Cas9 technique, we introduced loxP sites into the Il11ra1 gene locus to allow for the conditional deletion of exons 4 to 7 (transcript Il11ra1-204: ENSMUST00000108042.2) ( Figure 1A and Supplementary Figure 1, A and B) . Upon Cre recombinase-mediated excision, it was predicted that the excision of exons 4 and 7 would lead to the generation of a premature stop codon and truncation of the Il11ra1 protein just after the N-terminal signal peptide sequence of Il11ra1, resulting in a null allele.
Il11ra1-floxed mutant mice were generated on the C57BL/6 background and mice homozygous for the floxed allele (Il11ra1 loxP/loxP mice) were born in normal Mendelian ratios and appear healthy from birth and during adult life. Female Il11ra1 loxP/loxP mice were fertile, as compared to germline, global Il11ra1-deleted female mice, which showed that the insertion of loxP sequences had no detrimental effects on Il11ra1 gene function. Preliminary validation experiments were performed on fibroblasts isolated from the lungs of Il11ra1 loxP/loxP mice. After adenoviral delivery of Cre recombinase to Il11ra1 loxP/loxP fibroblasts, we confirmed a ~80% knockdown of Il11ra1 RNA as compared to cells transduced with control Adenovirus-GFP vectors (Supplementary Figure 1C) .
Next, to determine if IL11 signaling in fibroblasts is important for lung fibrogenesis. We crossed homozygous Il11ra1 loxP/loxP mice to mice that express tamoxifen-inducible Cre recombinase driven by the mouse collagen type I alpha 2 promoter (Col1a2-CreERT mice), to generate Col1a2-CreERT Il11ra1 loxP/loxP mice (Figure 1B and Supplementary Figure 2A ). To induce conditional knockdown of Il11ra1 in fibroblasts, we injected 8 week old female Col1a2-CreERT Il11ra1 loxP/loxP mice with tamoxifen (referred to as Il11ra1-CKO mice), while littermates controls were injected with corn oil (referred to as Il11ra1-Ctrl mice) ( Figure 1B) . After five days of tamoxifen treatment, there was a 56% reduction in IL11RA protein levels in whole lung lysates from Il11ra1-CKO mice, which may be expected given the robust expression of Il11ra1 on epithelial and vascular smooth muscle cells ( Figure 1C) (9, 10) . Furthermore, there was a 70% reduction of Il11ra1 mRNA expression in primary fibroblasts isolated from the lungs of Il11ra1-CKO mice as compared to cells from Il11ra1-Ctrl mice (Figure 1D) . In keeping with fibroblast-specific effects, tamoxifen treatment did not affect the expression of Il11ra1 in CD45positive cells from the lungs of Il11ra1-CKO mice.
Fibroblasts from mice with germline, global Il11ra1 deletion (Il11ra1 -/-) cannot upregulate fibrogenic proteins when stimulated with various fibrogenic stimuli, including TGFβ1 (2, 3). Thus, we examined the fibrogenic potential of TGFβ1 in lung fibroblasts isolated from Il11ra1-CKO mice. Lung fibroblasts were stimulated with recombinant mouse TGFβ1 (5 ng/ml; 24 hours) and activation monitored using automated high-throughput immunofluorescence imaging, collagen secretion and transwell matrigel invasion assays. Consistent with earlier studies, Il11ra1-CKO fibroblasts did not differentiate into myofibroblasts following TGFβ1 stimulation. Imaging analysis showed that ACTA2, COL1A1 expression and cell proliferation (as determined by EdU staining) were markedly decreased in TGFβ1-stimulated Il11ra1-CKO cells, as compared to controls (Figure 1E and Supplementary Figure 2 , B and C). Collagen secretion into the culture medium was also greatly reduced from TGFβ1-treated Il11ra1-CKO fibroblasts (Figure 1F ). Furthermore, recombinant mouse IL11 induced robust activation of Il11ra1-Ctrl fibroblasts, whereas the fibrotic response was greatly reduced in IL11-treated Il11ra1-CKO fibroblasts (Figure 1, E and F) . Activated myofibroblasts acquire an invasive phenotype and we have shown that IL11 is crucial in the regulation of this process (3) . We tested the ability of Il11ra1-CKO fibroblasts to invade ECM-coated Matrigel matrix, and found that l11ra1-CKO fibroblasts had reduced invasive capacity as compared to controls ( Figure 1G ).
Next, we determined the effect of fibroblast-specific Il11ra1 deletion on the development of lung fibrosis using the bleomycin (BLM) model of pulmonary injury, which we characterised previously (3) . Col1a2-CreERT Il11ra1 fl/fl mice mice were injected with five doses of tamoxifen prior to BLM challenge and administered an additional four additional doses post-BLM to maintain Il11ra1 suppression in fibroblasts populations (Figure 2A) . Histological examination of the lungs from saline-treated Il11ra1-CKO mice appeared normal. Following BLM injury (day 21), histology analysis revealed marked and highly significant reduction (84%, P=0.0042) in collagen accumulation and lung damage in Il11ra1-CKO mice as compared to controls ( Figure  2 , B and C). Consistent with the histology, lung weights and lung hydroxyproline content of BLM-treated Il11ra1-CKO mice were similarly significantly and profoundly decreased (reduction: 74%, P=0.0002; 82%, P=0.0005, respectively) as compared to controls (Figure 2, D and E) . The BLM model of lung injury is characterized by a strong initial inflammatory response which correlates with the extent of fibrosis at later time points (11) . We evaluated whether the inactivation of Il11ra1 in fibroblasts altered lung inflammatory responses and/or leukocyte recruitment following BLM. Western blot analysis of p-NF-kB, a pivotal mediator of inflammation across the spectrum of innate and acquired immune cells (12) , revealed that Il11ra1-deletion in fibroblasts markedly reduced NF-kB activation in total lung lysates after BLM injury ( Figure 3A) . Gene expression analysis of Il1b, Il6, Ccl2 and Cxcl1 by qRT-PCR showed a reduction in the innate inflammatory response (Figure 3B) . To examine further these anti-inflammatory effects, we studied leukocyte abundance in the lungs by immunostaining for CD45. This showed that Il11ra1-CKO mice had significantly reduced CD45 +ve immune cell lung infiltrates on day 21 post-BLM (Figure 3C and Supplementary Figure 3A) .
To examine the effects of Il11ra1-deletion in fibroblasts on what appeared to be downstream inflammatory responses in greater detail we used mass cytometry (CyTOF) (8, 13) to profile immune cell types in single cell suspensions of lung tissues from Il11ra1-Ctrl, -CKO mice and uninjured controls 14 days after BLM injury. As expected, we observed greater numbers of neutrophils, monocytes and macrophages in the lungs of BLM-treated Il11ra1-Ctrl mice as compared to uninjured controls. These cell populations were notably reduced in the lungs of BLM-treated Il11ra1-CKO as compared to Il11ra1-Ctrl (Figure 3D) . We further profiled the infiltrating immune cell populations based on their pro-fibrotic potential and documented specific reductions in Ly6C +ve TGFβ1 +ve cells in PMA-stimulated CD45 +ve cells from the lungs of Il11ra1-CKO mice as compared to Il11ra1-Ctrl (Figure 3, E and F) . These data, along with our previous findings (3), show that IL11 signaling in fibroblasts is both necessary and sufficient for lung inflammation in the BLM model of lung injury. This places stromal-driven inflammation at the apex of the inflammatory response in the fibrotic lung in the BLM model of lung injury.
We next determined the activation status (phosphorylation) of ERK and STAT3, both of which have been implicated in the pathogenesis of BLM-induced lung injury (3, 14) . Western blot analysis of lung homogenates showed robust activation of ERK1/2 and STAT3 in BLMchallenged Il11ra1-Ctrl mice (Figure 4A) . In contrast, Il11ra1-CKO mice showed significant reduction in both ERK1/2 and STAT3 activation after bleomycin ( Figure 4A ). Next, we used immunofluorescence and confocal imaging to localize the expression of activated ERK and STAT3 in BLM-injured lungs. In Il11ra1-Ctrl mice, we detected high levels of both phosphorylated ERK and STAT3 in fibrotic regions, which were reduced in lung sections from Il11ra1-CKO mice ( Figure 4B) . Interestingly, phosphorylated STAT3 was most highly expressed in cells of leukocyte morphology and less prominent in the stroma. Consistent with this, immunostaining for both CD45 and p-STAT3 revealed that p-STAT3 colocalized to leukocytes, and that the proportions of these double positive cells were reduced in the lungs of Il11ra1-CKO mice (Supplementary Figure 3B) .
To determine if the reduction in the activation of ERK, STAT3 or NF-kB in lung lysates following fibroblast-specific Il11ra1 deletion was due to lesser activation in fibroblasts, we isolated primary lung fibroblasts from Il11ra1-Ctrl and Il11ra1-CKO mice 14 days after BLM injury. Western blot analysis of primary fibroblast lysates showed a significant reduction in ERK activation in Il11ra1-CKO fibroblasts as compared to controls. In contrast, fibroblasts from BLMtreated Il11ra1-CKO mice had similar p-STAT3 and p-NF-kB levels when compared to Il11ra1-Ctrl (Figure 3C and Supplementary Figure 3C) . Thus the overall reduction in p-STAT3 and p-NF-kB in the lungs of BLM-treated Il11ra1-CKO mice reflects reduced abundance of infiltrating inflammatory cells. Whereas, lower ERK activation in lung lysates from Il11ra1-CKO mice reflects lesser ERK activation in activated pulmonary fibroblasts.
We have previously identified a central role for IL11 signaling in fibrotic disease of the heart, liver and lung (2, 3, 8) . Chronic disease is often characterized by localized inflammation and resident sentinel cells, which can be of mesenchymal or immune lineages, are important determinants of this tissue-specific immune response (6, 15) . To better understand the contribution of IL11 signaling in specific cell types in disease pathology, we created the Il11ra1 loxP/loxP mouse for temporal and conditional inactivation of the Il11ra1 gene.
Confirming our previous observations using global, germline Il11ra1 deleted mice or neutralizing antibodies (3), adult pulmonary fibroblasts conditionally lacking IL11 signaling are unresponsive to pro-fibrotic stimuli in vitro (Figure 1) . Histological scoring of lung damage and monitoring of RNA-and protein-based markers of pulmonary fibrosis revealed that Il11ra1-CKO mice are protected from BLM-induced lung fibrosis. These data define the critical role of IL11dependent fibroblast activation in pathogenic ECM deposition in the BLM lung fibrosis model (Figure 2) .
While fibroblasts have been implicated in inflammation-associated pathology of rheumatoid arthritis, colitis and IPF (7, (15) (16) (17) (18) , it has not been shown conclusively whether the stroma is a modifier or primary driver of the inflammatory response. In the BLM model of lung fibrosis, we found that the deletion of IL11 signaling in fibroblasts alone is sufficient to protect mice from inflammation in the lung. Remarkably, following BLM injury Il11ra1-CKO mice showed minimal activation of the NF-kB pathway, which is the prototypical activator of both the innate and acquired immune system (12) , whereas control mice had marked induction of p-NF-kB. Other pro-inflammatory markers, such as Il1b or Il6 were also suppressed in Il11ra1-CKO mice following BLM. Il11ra1-deletion in fibroblasts also reduced the expression of chemokines such as Ccl2 and Cxcl1 and blocked pulmonary infiltration of Ly6C +ve neutrophils, monocytes and macrophages (Figure 3) . Ly6C +ve macrophages have been shown to drive fibrosis, in-part via their interactions with stromal cells (19) (20) (21) . Similarly, neutrophilic infiltration contributes to BLMinduced lung fibrosis via their release of neutrophil elastase, which promotes TGFβ activation and myofibroblast differentiation (22) (23) (24) (25) . Our observations suggest that stromal cells are not only activated by immune cells, but also of central importance for their recruitment. Deactivation of the stroma via IL11 neutralization can break the vicious cycle of pathologic stroma-and immune-cell crosstalk and prevent both fibrosis and inflammation in IPF.
Western blotting of whole lungs revealed that both STAT3 (viewed as canonical downstream of GP130), as well as non-canonical ERK signaling, were reduced in the BLM damaged lungs of l11ra1-CKO mice (Figure 4A) . This is perhaps surprising, as we genetically block IL11 signaling in fibroblasts only in Il11ra1-CKO mice and we have also shown previously that IL11 at physiological levels primarily activates ERK, but not STAT3, signaling in fibroblasts in vitro (2, 3, 8) .
To identify the cellular compartment(s) characterized by ERK and/or STAT activation, we performed immunostaining of lung sections using p-ERK and p-STAT3 antibodies. In BLMtreated control animals, ERK activation was detected in clusters of spindle-shaped fibroblast-like cells. In contrast, STAT3 activation was localized to a different, round-shaped, cell-type, which we showed to be CD45 +ve immune cells (Supplementary Figure 3) . In the l11ra1-CKO mouse, ERK activation was reduced in the stromal compartment, which we confirmed ex vivo in primary fibroblast cultures (Figure 4C) . We suggest this is likely a direct effect of IL11 inhibition on this cell type. Immunostaining of lung sections showed STAT3 activity in immune cells still occurred in the Il11ra1-CKO but that number of CD45 +ve cells was greatly reduced. Thus the antiinflammatory properties of IL11 neutralization appear to be indirect and reflect a less activated stroma (Figure 3) . Western blotting of the whole lung lysates thus shows a reduction in p-STAT3 +ve cells and does not indicate a reduction of STAT3 activation in stromal or parenchymal cells.
Our data support the growing concept that fibroblasts are immunologically active and show that Il11ra1-dependent fibroblast activation can lead to inflammation (6) . Further studies are required to delineate whether distinct subpopulations of IL11-responsive fibroblasts drive lung fibrosis and inflammation. It will also be important to examine whether IL11-dependent, fibroblast-mediated inflammation occurs in other lung diseases, such as asthma (26, 27) or additional conditions such as rheumatoid arthritis or colitis (15) (16) (17) (18) . Preliminary functional studies suggest this may be the case, at least for colitis (10) , which is characterized by IL11expressing inflammatory fibroblasts that predict disease severity in patients (17) .
METHODS

Study approval.
Animal studies were performed in accordance to approved protocols by the SingHealth Institutional Animal Care and Use Committee (IACUC). 
SUPPLEMENTAL METHODS
Animal models.
Generation of Il11ra1 floxed mice. CRISPR/Cas9 technique was used to introduce loxP sequences into the Il11ra1 gene (ENSMUSG00000073889; Transcript Il11ra1-204: ENSMUST00000108042.2) to allow for the conditional deletion of exons 4 to 7, which will result in a null allele upon Cre recombinase-mediated excision. Single guide RNAs (sgRNAs) with recognition sites on introns 4 and 7 along with Cas9 and a targeting construct containing two loxP sequences were microinjected into fertilized zygotes, and subsequently transferred into pseudopregnant mice (Shanghai Model Organisms Center, Inc). Insertion of loxP sites into the Il11ra1 gene locus were verified by sequencing. Mutant Il11ra1-floxed offspring were generated on a C57BL/6 background and identified by genotyping to detect the insertion of a loxP site in intron 7 using the following primers: 5'-CATTACCTACACATCCTTCCC-3' and 5'-CCTCCCACACTCAGATTAAGA-3'.
Generation of fibroblast-specific Il11ra1 knockout mice. To direct fibroblast-specific Il11ra1 deletion in mice, homozygous Il11ra1-floxed mice (Il11ra1 loxP/loxP ) were crossed with hemizygous Col1a2-CreERT mice (28) (Jackson's Lab) to generate Col1a2-CreERT Il11ra1 loxP/loxP progenies. Six to eight week old Col1a2-CreERT; Il11ra1 loxP/loxP mice received intraperitoneal injections of tamoxifen (50 mg kg -1 body weight) per day for 5 consecutive days before bleomycin challenge, followed by subsequent tamoxifen injections at day 7, 11, 14 and 17 after bleomycin challenge to delete Il11ra1 from fibroblast populations (Il11ra1-CKO mice). Littermate animals were injected with corn oil as vehicle as controls (Il11ra1-Ctrl mice).
Bleomycin model of lung injury. Mice were anesthetized by isoflurane inhalation and bleomycin (Sigma-Aldrich) was administered oropharyngeally at a dose of 1 mg kg -1 body weight or saline as sham controls.
Antibodies and reagents.
Antibodies: Anti-ACTA2 (ab7817, abcam), anti-COL1A1 (ab34710, abcam), anti-COL3A1 antibody (sc-271249, Santa Cruz), anti-Fibronectin antibody (ab2413, Abcam), anti-p-ERK1/2 (4370, Cell Signaling), anti-ERK1/2 (4695, Cell Signaling), anti-p-STAT3 (4113, Cell Signaling), anti-STAT3 (4904, Cell Signaling), anti-GAPDH (2118, Cell Signaling), anti-CD45 (ab10558, abcam), p-NF-kB (3033, Cell Signaling), NF-kB (8242, Cell Signaling) and anti-IL11RA (130920, Santa Cruz). Recombinant proteins: TGFβ1 (7666-MB, R&D Systems), PDGF (220-BB, R&D Systems) and recombinant mouse IL11 (GenScript).
Primary lung fibroblast cultures.
Primary mouse lung fibroblasts were isolated from 8-12 week old Il11ra1-CKO and Il11ra1-Ctrl mice after 5 consecutive doses of tamoxifen (1 mg/kg) or corn oil respectively. Lungs were minced, digested for 30 minutes in DMEM containing 100 U ml -1 penicillin, 100 μg ml -1 streptomycin and 0.14 Wunsch U ml -1 Liberase (Roche) with mild agitation. Lung tissue were washed and subsequently cultured in complete DMEM supplemented with 15% FBS, 100 U ml -1 penicillin and 100 μg ml -1 streptomycin at 37°C. Fibroblasts were enriched via negative selection with magnetic beads against mouse CD45 (leukocytes), CD31 (endothelial) and CD326 (epithelial) using a QuadroMACS separator (Miltenyi Biotec) according to the manufacturer's protocol. Mouse lung fibroblasts were used for downstream experiments between passages 3 to 5. To induce Cre recombinase expression, Il11ra1 loxP/loxP fibroblasts were transduced with Adenovirus-Cre-GFP (VectorBiolabs) or Adenovirus-CMV-GFP as control vector. One day after transduction, cells were lysed and mRNA expression of Il11ra1 were analysed by RT-qPCR.
In vitro immunofluorescence and image analysis.
Immunofluorescence imaging and quantification of fibroblast activation were performed on the Operetta High Content Imaging platform (PerkinElmer) as previously described (2) . Briefly, lung fibroblasts were seeded in 96-well CellCarrier plates (6005550, PerkinElmer) at a density of 5x10 3 cells per well and following experimental conditions, cells were fixed in 4% paraformaldehyde (28908, Life Technologies) and permeabilized with 0.1% Triton X-100 in PBS. EdU-Alexa Fluor 488 was incorporated using a Click-iT Edu Labelling kit (C10350, Life Technologies) according to manufacturer's protocol. Cells were blocked using 0.5% BSA and 0.1% Tween-20 in PBS before incubation with primary antibody (anti-ACTA2 or anti-COL1A1) and visualized using Alexa Fluor 488-conjugated secondary antibody (ab150113, Abcam). Cells were counterstained with DAPI (D1306, Life Technologies) in blocking solution. Plates were scanned and images were collected with an Operetta high-content imaging system 1483 (PerkinElmer). Each experiment was run in duplicate wells, 7 fixed fields per well were measured and data points from duplicate wells were combined for a total of n = 14 measurements per condition. The percentage of activated fibroblasts (ACTA2 + cells) and EdU + cells in each field was quantified using the Harmony software version 3.5.2 (PerkinElmer). The measurement of COL1A1 fluorescence intensity was done using Columbus software version 2.7.1 (PerkinElmer). Fluorescence intensity for COL1A1 staining was normalized to the cell area detected in each field. Representative results using primary cells of one individual mouse are shown in the manuscript as described in the figure legends.
Matrigel invasion assay.
The invasive capacity of lung fibroblasts isolated from Il11ra1-CKO and Il11ra1-Ctrl mice were assayed using Boyden chamber invasion assay (Cell Biolabs Inc.). Equal numbers of fibroblasts in serum-free DMEM were seeded in duplicates onto ECM-coated matrigel and allowed to invade towards DMEM containing 2% FBS and PDGF (20 ng ml -1 ) as chemoattractants. After 24h of incubation at 37°C, media was removed and non-invasive cells were removed using cotton swabs. The cells that migrated or invaded towards the bottom chamber were stained with cell staining solution (Cell Biolabs Inc.). Invasive cells from 5 non-overlapping fields of each membrane were imaged and counted under 40x magnification.
Histology.
Freshly dissected mouse lungs were fixed in 10% Neutral buffered formalin for 24h, embedded in paraffin and sectioned for staining. For Masson's trichrome staining of lung sections were described previously (3) . Fibrosis scores in Masson's trichrome stained lung sections were assessed using the Ashcroft score (29), and histopathological scoring was performed blinded to genotype and bleomycin treatment. For immunostaining of lung tissues, mouse lungs were firstly fixed overnight in 4% paraformaldehyde (Thermofisher) at 4˚C, dehydrated in 20% sucrose in PBS for 72 hours and frozen in Optimal cutting temperature compound (OCT) prior to sectioning. Fifteen micrometer cryosections were first permeabilized with 0.1% Triton X-100 for 30 minutes and then blocked in 3% bovine serum albumin in PBS for 30 minutes. Primary antibodies concentrations were then applied according to manufacturer's instructions and incubated at 4°C overnight, followed by secondary antibody incubation for 30 minutes at room temperature (anti-mouse or rabbit Alexa Fluor-555 and -647, Molecular Probes). Sections were mounted with ProLong glass antifade mountant (Molecular probes) and fluorescence images were acquired using a confocal laser scanning microscope (LSM 710, Zeiss).
Colorimetric assays.
For the detection of secreted collagen by cells in culture, the supernatant was first concentrated using polyethylene glycol solution (90626 Chondrex) prior to quantification using a Sirius red
